[Muscle relaxants in the ICU].
Neuromuscular blockade in ICU patients has become less popular, in particular since non-invasive methods of artificial respiration have been introduced. Succinylcholine has numerous side effects. Due to its short onset, Rocuronium may be an alternative. The advantage of Atracurium and Cis-Atracurium is a largely organ-independent metabolism. In ICU patients, neuromuscular monitoring should be applied. Prolonged action and critical illness neuropathy are the most prominent side effects of neuromuscular blockade.
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München. g.schneider@lrz.tumuenchen.de
Gerhard
G
Schneider
D000732:Androstanols / Q000009:adverse effects / Q000627:therapeutic use; D001279:Atracurium / Q000009:adverse effects / Q000627:therapeutic use*; D016638:Critical Illness; D006801:Humans; D007036:Hypothermia, Induced; D007362:Intensive Care Units; D009045:Motor Endplate / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced; D019148:Neuromuscular Blockade / Q000379:methods*; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D011014:Pneumonia / Q000139:chemically induced; D000077123:Rocuronium; D018805:Sepsis / Q000517:prevention & control; D013390:Succinylcholine / Q000009:adverse effects / Q000627:therapeutic use*; D013923:Thromboembolism / Q000139:chemically induced / Q000517:prevention & control; D014673:Vecuronium Bromide / Q000009:adverse effects / Q000627:therapeutic use
D000732:Androstanols; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D013390:Succinylcholine; D000077123:Rocuronium